Literature DB >> 28260914

Helicobacter pylori infection is not associated with failure to thrive: a case control study.

Nan-Chang Chiu1, Chien-Yu Lin2, Hsin Chi3, Chun-Yan Yeung1, Wei-Hsin Ting3, Wai-Tao Chan3, Chuen-Bin Jiang3, Sung-Tse Li4, Chao-Hsu Lin2, Hung-Chang Lee1.   

Abstract

PURPOSE: The long-term impact of Helicobacter pylori infection is complex, and concerns about the need for eradication exist. We conducted this case control study to investigate the association between H. pylori infection and failure to thrive (FTT). PATIENTS AND METHODS: From January 2009 to December 2011, 53 children with FTT group and matched children with the same sex and age and similar socioeconomic status without FTT (control group) were enrolled. A questionnaire was administered to the parents/guardian, and a 13C-urea breath test was performed to detect H. pylori infection.
RESULTS: We found that the total prevalence of H. pylori infection was 29.2% and that there was no association between FTT and H. pylori infection (FTT group: 32%; control group: 26.4%; P=0.67). Short stature was more common in the FTT group and abdominal pain in the control group (FTT group: 37.7%; control group: 11.3%; P=0.003). In a comparison between the H. pylori-positive and -negative groups, abdominal pain (87.1% vs 64%; P=0.032) and the frequency of endoscopy (74.2% vs 32%; P<0.001) were significantly more common in the H. pylori-positive group.
CONCLUSION: We found that children with H. pylori infection are at an increased risk for abdominal pain and that FTT is not associated with H. pylori infection. The decision for eradication should be evaluated carefully and individualized.

Entities:  

Keywords:  13C-urea breath test; Helicobacter pylori; children; failure to thrive; growth retardation

Year:  2017        PMID: 28260914      PMCID: PMC5328124          DOI: 10.2147/TCRM.S123148

Source DB:  PubMed          Journal:  Ther Clin Risk Manag        ISSN: 1176-6336            Impact factor:   2.423


Introduction

Helicobacter pylori infection is one of the most common causes of chronic infection and is associated with a variety of disorders. The prevalence of H. pylori infection ranges from approximately 10% to 90% and is influenced by country, age, socioeconomic background, nutritional status, urbanization, and hygiene.1–4 While its prevalence appears to be declining in developed countries, it remains a major problem in developing nations.4 The transmission pathway remains highly controversial and has not yet been definitively elucidated. Infection among family members is common, and the oral–oral route seems to be the most probable transmission pathway. Moreover, risk factors for infection are associated with a lower socioeconomic status, including overcrowding, unhygienic conditions, sharing beds during childhood, and a low maternal educational level.5,6 H. pylori infection is associated with several disorders, but the impact of infection is a subject of debate. In general, gastric infection with H. pylori is a risk factor for the development of chronic gastritis, peptic ulcers, gastric adenocarcinoma, short stature, and iron deficiency anemia (IDA).7–11 H. pylori infection is also associated with a number of extragastric disorders, such as eye, skin, respiratory, and psychiatric disorders.7,12–15 However, H. pylori infection may be beneficial for several diseases, such as asthma, obesity, and inflammatory bowel disease.16–19 The role and pathophysiology of H. pylori remain poorly understood, and knowledge regarding infection continues to advance. Therefore, it is necessary to weigh the pros and cons of the need to screen and treat H. pylori infection. In addition, the impact of H. pylori infection on childhood growth and development is also controversial. Some studies suggest that gastric infection with H. pylori is associated with suboptimal nutrition and delayed growth during childhood. Although some studies have suggested that H. pylori infection affects growth,20 others disagree.21,22 To describe the clinical features of H. pylori infection and assess its role in the development of childhood malnutrition and growth retardation, we conducted this case control study. Specifically, we investigated the association between the weight-for-age of children and H. pylori infection in a randomly selected population of children with similar diets and socioeconomic backgrounds in Taiwan.

Patients and methods

Study design and population

This prospective case control study, approved by the Committee for Clinical Investigation at MacKay Memorial Hospital, was conducted from January 2009 to December 2011 (approval no: MMHIS639). Children aged 4–18 years with failure to thrive (FTT) were enrolled in our study. FTT was defined as unsatisfactory body weight-for-age (less than 15th percentile) per the recommendations of National Center for Health Statistics and previous studies.23 After a detailed explanation of the study, written informed consent was obtained from the children (whenever possible) and their parents. Children unable to perform the 13C-urea breath test (13C-UBT) were excluded. We also obtained information regarding age, sex, family income, overcrowding (ie, ratio of total residents per household to the number of rooms and number of persons per bed), type of water consumed, mother’s education, and breast-feeding. Once a child with FTT was enrolled in our study group, a matched child with the same age, sex, and similar socioeconomic status without FTT was assigned to the control group. One of the authors conducted the interviews, collected breath samples, and recorded the children’s height and weight. The 13C-UBT was performed in both groups to detect H. pylori infection, and the clinical manifestations, as well as the laboratory tests, were analyzed. Complete blood tests and biochemistry tests were performed and endoscopy done in some children with refractory abdominal pain. The need for an endoscopy depended on the clinical symptoms, treatment responses, and the judgment of pediatric gastrointestinal specialists.

Height and weight measurement

One of the authors recorded the standing height (cm) and weight (kg) for each subject. Standard deviation (SD) scores and the percentile values for weight and height were calculated for each child according to the National Center for Health Statistics (NCHS) standardized values for Taiwan.23 Children with a weight-for-age below the 15th percentile value were defined as FTT, and children with a height-for-age below the 15th percentile value were defined as having short stature.

13C-UBT

The 13C-UBT was performed after a fasting period of 6 h. After providing an initial breath sample, the children received a 100 mL glass of orange juice containing 50 mg 13C-urea (for those less than 30 kg) or 75 mg of 13C of urea (for those more than 30 kg). A second breath sample was collected 30 min later. The samples were analyzed with an infrared spectrometer (IRIS; Wagner Isotope Analysen Technik, Bremen, Germany). The results were considered positive when the delta over baseline (DOB) was 4.0.5,24

Statistical analyses

Data were analyzed using Statistical Package for the Social Sciences (SPSS) version 15 (SPSS Inc., Chicago, IL, USA). Categorical variables were compared using the χ2 test and the Fisher’s exact test. Continuous variables were compared using the Student’s t-test. A multivariate logistic regression model was used to assess the independent effect of H. pylori status and the percentile for weight. P<0.05 was considered statistically significant. Variables with P-values <0.25 were included in the logistic regression model, such as short stature and abdominal pain. Odds ratio (OR) and 95% confidence intervals (CIs) were used as an estimate of the risk. The Hosmer–Lemeshow goodness-of-fit test was used to evaluate the fit of the models. The nutritional status was scored using the EPINUT program (EpiInfo, version 6; CDC, Atlanta, GA, USA).

Results

About 106 children were enrolled in our study (n=53 in the FTT group and n=53 in the control group). Of these, 64 (60.4%) were boys, and the mean age was 11±3.74 years. The overall prevalence of H. pylori infection was 29.2%, with 32% in the FTT group and 26.4% in the control group, but this difference was not statistically significant (P=0.67) (Table 1). Short stature was found to be more common in children with FTT (37.7% vs 11.3%; P=0.003), but the frequency of abdominal pain was lower (56.6% vs 84.9%; P=0.003). Myopia was reported in six children in the control group, but none in the FTT group. Endoscopy was performed in 47 (44.3%) children, and gastritis/gastric ulcer was the most common finding (40, 85.1%). In a comparison between the H. pylori-positive and -negative groups, the children with H. pylori infection were found to be older and predominantly male (Table 2). In addition, abdominal pain (87.1% vs 64%; P=0.032) and the frequency of endoscopy (74.2% vs 32%; P<0.001) were significantly more common in the H. pylori-positive group. Our findings indicate that H. pylori infection was not associated with FTT in this case control study. Furthermore, FTT was associated with short stature, while children with H. pylori infection were at a higher risk for developing abdominal pain.
Table 1

Characteristics of the FTT and control groups

Clinical characteristicsOverall(n=106)FTT group(n=53)Control group(n=53)P-value
Age, years11±3.7411±3.7611±3.76>0.99
Male, n (%)64 (60.4)32 (60.4)32 (60.4)
HP infection, n (%)31 (29.2)17 (32.0)14 (26.4)0.67
Short stature, n (%)26 (24.5)20 (37.7)6 (11.3)0.003*
Clinical symptoms
 Abd pain, n (%)75 (70.8)30 (56.6)45 (84.9)0.003*
 Constipation, n (%)27 (25.5)13 (24.5)14 (26.4)>0.99
 GERD, n (%)26 (24.5)10 (18.9)16 (30.2)0.26
Associated diseases
 Asthma11 (10.4)4 (7.5)7 (13.2)0.52
 Allergic rhinitis21 (19.8)8 (15.1)13 (24.5)0.33
 Myopia6 (5.7)0 (0)6 (11.3)0.036*
 ADHD14 (13.2)6 (11.3)8 (15.1)0.77
Laboratory tests
 IDA15 (22.7)6 (22.2)9 (23.1)0.83
 PES47 (44.3)18 (34.0)29 (54.7)0.05
 EU11 (23.4)4 (22.2)7 (24.1)0.84
 GU40 (85.1)15 (83.3)25 (86.2)0.88
 DU32 (68.1)12 (66.7)20 (69.0)0.87

Notes: For categorical variables, the results are expressed as number (%), and for continuous variables, the results are expressed as mean ± standard deviation. A P-value <0.05 was considered statistically significant between FTT and control groups and indicated by an asterisk (*).

Abbreviations: HP, Helicobacter pylori; Abd pain, abdominal pain; GERD, gastroesophageal reflux disease; ADHD, attention deficit hyperactivity disorder; IDA, iron deficiency anemia; PES, endoscopy; EU, esophagitis/esophageal ulcer; GU, gastritis/gastric ulcer; DU, duodenitis/duodenal ulcer; FTT, failure to thrive.

Table 2

Comparison between Helicobacter pylori-positive and -negative groups

Clinical characteristicsOverall(n=106)HP (+) group(n=31)HP (−) group(n=75)P-value
Age, years11±3.7412.8±3.4110.25±3.640.75
Male, n (%)64 (60.4)22 (71.0)42 (56.0)0.22
FTT, n (%)53 (50.0)17 (54.8)36 (48.0)0.67
Short stature, n (%)26 (24.5)9 (29.0)17 (22.7)0.67
Clinical symptoms
 Abd pain, n (%)75 (70.8)27 (87.1)48 (64.0)0.032*
 Constipation, n (%)27 (25.5)8 (25.8)19 (25.3)0.85
 GERD, n (%)26 (24.5)9 (29.0)17 (22.7)0.66
Associated diseases
 Asthma11 (10.4)2 (6.5)9 (12.0)0.62
 Allergic rhinitis21 (19.8)4 (12.9)17 (22.7)0.38
 Myopia6 (5.7)2 (6.5)4 (5.3)0.81
 ADHD14 (13.2)2 (6.5)12 (16.0)0.31
Laboratory tests
 IDA15 (22.7)8 (25.8)7 (9.3)0.08
 PES47 (44.3)23 (74.2)24 (32.0)<0.001*
 EU11 (23.4)6 (26.0)5 (20.8)0.94
 GU40 (85.1)21 (91.3)19 (79.2)0.45
 DU32 (68.1)18 (78.3)14 (58.3)0.25

Notes: For categorical variables, the results are expressed as number (%), and for continuous variables, the results are expressed as mean ± standard deviation. A P-value <0.05 was considered statistically significant between HP (+) and HP (−) groups and indicated by an asterisk (*).

Abbreviations: HP, Helicobacter pylori; Abd pain, abdominal pain; FTT, failure to thrive; GERD, gastroesophageal reflux disease; ADHD, attention deficit hyperactivity disorder; IDA, iron deficiency anemia; PES, endoscopy; EU, esophagitis/esophageal ulcer; GU, gastritis/gastric ulcer; DU, duodenitis/duodenal ulcer.

Discussion

Infection with H. pylori is common, and the disease burden is substantial. The prevalence of H. pylori infection differs according to country, ethnicity, age, socioeconomic background, nutritional status, urbanization, public hygiene, and diagnostic tools available.1–4 As general public hygiene and sanitation improved, the infection rate has been decreasing.4 Chi et al1 reported that the H. pylori infection rate based on 13C-UBT in a rural area in Taiwan was 54.7% in 2008. Mackay Memorial Hospital is a tertiary referral hospital in an urban area, and the prevalence of H. pylori infection in the current study was 29.2%. In addition, the different diagnostic methods used in each study also impact the prevalence. Endoscopic culture is the gold standard for diagnosis, but is not readily available for children.6,25 A serum immunoglobulin G (IgG) test is relatively noninvasive and widely used but should be interpreted with caution.25 Another study that measured H. pylori infection via serum IgG levels found that there was a prevalence of 15.1% in central, urban Taiwan in 2006.3 In addition, a systematic review assessing the prevalence of H. pylori infection in the People’s Republic of China and the US according to the serum IgG levels shows a weighted mean prevalence of 66% for Chinese rural populations and 47% for Chinese urban populations.4 The weighted prevalence in the US from 1990 to 2006 was 35%.4 13C-UBT is noninvasive, highly sensitive, and specific and thus could be used to investigate epidemiological results and assess the efficacy of eradication therapy.24–26 In general, H. pylori infection is common in both developed and developing countries and warrants our attention. While infection with H. pylori infection is common, the various effects of the disease are complex. It is associated with many disorders, and the strongest association is with chronic gastritis and peptic ulcers.7 Our findings also support this association. In addition, patients with H. pylori infection have a higher risk of gastric adenocarcinoma.11,27 Higher risk of colorectal neoplasia in patients with H. pylori infections is also reported.28 The unfavorable influences of H. pylori include a short stature and IDA,29 although these were not evident in our study. However, H. pylori infection does not always have negative consequences, and some effects may be beneficial. For example, a cross-sectional study revealed that adults younger than 40 years of age with an H. pylori infection had an inverse correlation with asthma (OR: 0.503).30 The beneficial relationship between H. pylori infection and other atopic diseases, obesity, and inflammatory bowel disease has also been demonstrated.7,16,17,19,31 Therefore, the decision to screen and eradicate infection with H. pylori should be individualized, and the pros and cons weighed. Growth and FTT are an important but complex issue, and thus, assessing the association between H. pylori infection and growth is highly complex. Some studies report that H. pylori may cause FTT, but the evidence is conflicting.20,22,32 We have summarized the findings of some studies in Table 3.1,20,21,32–35 The nature of the case control design could decrease these influencing factors. Our study reveals that there is no association between FTT and H. pylori infection. Therefore, physicians should not overtreat H. pylori-infected children with FTT.
Table 3

Studies investigating the association between Helicobacter pylori and FTT

StudyCountryMethodPrevalence of H. pyloriAssociated with FTT?
Richter et al20 (2001)Germany13C-UBTBoys: 7.2%Yes for boys
Girls: 6.1%No for girls
Özçay et al21 (2002)Turkey13C-UBT, histology55.1%No
Miller et al33 (2003)USASerum IgG antibodies31.0%No
Sood et al34 (2005)UK13C-UBT37.7%Yes
Chi et al1 (2009)Taiwan13C-UBT54.7%No
Kopácová et al35 (2014)Czech Republic13C-UBT23.5%No
Muhsen et al32 (2015)IsraelStool antigen53.0%No
Current studyTaiwan13C-UBT29.2%No

Abbreviations: 13C-UBT, 13C-urea breath test; FTT, failure to thrive; IgG, immunoglobulin G.

We found that abdominal pain (87.1% vs 64%; P=0.032) and the frequency of endoscopy (74.2% vs 32%; P<0.001) were significantly more common in the H. pylori-positive group. There are concerns about whether endoscopy may increase the risk of H. pylori infection. The 13C-UBT was performed on children before undergoing endoscopy in our study; hence, the diagnosis of H. pylori was not affected by the endoscopy. Furthermore, Ribeiro et al36 found the efficacy of endoscope disinfection was excellent. No detectable transmission of H. pylori was noted when sterilized biopsy forceps and stringent disinfection standards were employed.

Limitations

Our study had some limitations. First, endoscopy was not routinely performed, and bacterial cultures were not obtained. According to the guidelines of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN); the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN); and other studies, culture-guided eradication contributes to successful treatment owing to the increase in drug resistance, and the regimen of eradication therapy is changing.6,37 However, it is relatively invasive and is not readily available in children. Therefore, culture-guided treatment is not routinely used in children, and 13C-UBT is a useful substitute to evaluate the response of eradication.7 Second, assessing the association between H. pylori infection and growth is multifactorial and highly complex. The design of the case control study could minimize the influence of covariates, but the case number is still not adequate in the current study. Further large-scale case control study is warranted to consolidate the association between H. pylori infection and FTT.

Conclusion

In conclusion, H. pylori infection is common, and its role and impact on growth remain controversial. The present study compared the H. pylori infection status in children with FTT and a matched control group. Our findings indicate that there is no association between FTT and H. pylori infection. Therefore, physicians should not overtreat H. pylori-infected children with FTT. The decision for eradication should be evaluated carefully and individualized.
  37 in total

1.  Growth in children with Helicobacter pylori infection and dyspepsia.

Authors:  M R Sood; S Joshi; A K Akobeng; J Mitchell; A G Thomas
Journal:  Arch Dis Child       Date:  2005-06-14       Impact factor: 3.791

2.  Five- to 7-year-old children with Helicobacter pylori infection are smaller than Helicobacter-negative children: a cross-sectional population-based study of 3,315 children.

Authors:  T Richter; T Richter; S List; D M Müller; J Deutscher; H H Uhlig; P Krumbiegel; O Herbarth; F J Gutsmuths; W Kiess
Journal:  J Pediatr Gastroenterol Nutr       Date:  2001-10       Impact factor: 2.839

Review 3.  Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits.

Authors:  David Y Graham
Journal:  Gastroenterology       Date:  2015-02-02       Impact factor: 22.682

Review 4.  Helicobacter pylori infection and atopic diseases: is there a relationship? A systematic review and meta-analysis.

Authors:  Elena Lionetti; Salvatore Leonardi; Angela Lanzafame; Maria Teresa Garozzo; Martina Filippelli; Stefania Tomarchio; Viviana Ferrara; Carmelo Salpietro; Alfredo Pulvirenti; Ruggiero Francavilla; Carlo Catassi
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

5.  An optimized 13C-urea breath test for the diagnosis of H pylori infection.

Authors:  Germán Campuzano-Maya
Journal:  World J Gastroenterol       Date:  2007-11-07       Impact factor: 5.742

6.  The association between Helicobacter pylori infection and inflammatory bowel disease based on meta-analysis.

Authors:  T Rokkas; J P Gisbert; Y Niv; C O'Morain
Journal:  United European Gastroenterol J       Date:  2015-12       Impact factor: 4.623

7.  Helicobacter pylori Infection in Children: Nutritional Status and Associations with Serum Leptin, Ghrelin, and IGF-1 Levels.

Authors:  Gulin Erdemir; Tanju Basarir Ozkan; Taner Ozgur; Derya Altay; Sinan Cavun; Guher Goral
Journal:  Helicobacter       Date:  2015-12-15       Impact factor: 5.753

8.  Inverse correlation between Helicobacter pylori colonization and obesity in a cohort of inner city children.

Authors:  Hanh D Vo; Sridhar Goli; Rupinder Gill; Virginia Anderson; Dimitre G Stefanov; Jiliu Xu; Nazia Kulsum-Mecci; Steven M Schwarz; Simon S Rabinowitz
Journal:  Helicobacter       Date:  2014-10-11       Impact factor: 5.753

Review 9.  Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis.

Authors:  Yi-Chia Lee; Tsung-Hsien Chiang; Chu-Kuang Chou; Yu-Kang Tu; Wei-Chih Liao; Ming-Shiang Wu; David Y Graham
Journal:  Gastroenterology       Date:  2016-02-02       Impact factor: 22.682

Review 10.  Helicobacter pylori infection and eye diseases: a systematic review.

Authors:  Sergio Claudio Saccà; Aldo Vagge; Alessandra Pulliero; Alberto Izzotti
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

View more
  3 in total

1.  Helicobacter pylori infection and severity of coronary atherosclerosis in patients with chronic coronary artery disease.

Authors:  Anita Jukic; Dorotea Bozic; Dusko Kardum; Tina Becic; Bruno Luksic; Mislav Vrsalovic; Marko Ljubkovic; Damir Fabijanic
Journal:  Ther Clin Risk Manag       Date:  2017-07-27       Impact factor: 2.423

2.  Helicobacter pylori infection is associated with fecal biomarkers of environmental enteric dysfunction but not with the nutritional status of children living in Bangladesh.

Authors:  Shah Mohammad Fahim; Subhasish Das; Md Amran Gazi; Md Ashraful Alam; Md Mehedi Hasan; Md Shabab Hossain; Mustafa Mahfuz; M Masudur Rahman; Rashidul Haque; Shafiqul Alam Sarker; Ramendra Nath Mazumder; Tahmeed Ahmed
Journal:  PLoS Negl Trop Dis       Date:  2020-04-23

3.  Effects of Helicobacter pylori Infection on Ghrelin and Insulin-like Growth Factor 1 Secretion in Children with Idiopathic Short Stature.

Authors:  Marzena Kolasa-Kicińska; Renata Stawerska; Paweł Stawerski; Andrzej Kałużyński; Elżbieta Czkwianianc; Andrzej Lewiński
Journal:  J Clin Med       Date:  2022-10-04       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.